RPGLIFE Share Price Performance
Recent RPGLIFE News & Updates
No updates
RPG Life Sciences Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 110.51
- Gross Margin
- 65.86%
- Net Profit Margin
- 27.82%
- Debt/Equity Ratio
- 0%
RPG Life Sciences Limited Competitors
About RPGLIFE
- Founded
- 1968
- Employees
- 1331
- CEO
- WebsiteView website
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology and pediatrics, cardiovascular, pediatrics, neurology, anti-dengue, dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.
Indian Market Performance
- 7 Days: -1.8%
- 3 Months: 5.5%
- 1 Year: -6.0%
- Year to Date: -0.3%
Over the last 7 days, the market has dropped 1.8%, driven by a loss of 2.7% in the Financials sector. In the last 12 months the market is down 6.0%. Earnings are forecast to grow by 15% annually. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading